Overview
July 18, 2008
San Antonio, TX
July 19, 2008
Denver, CO
Statement of Need/Program Overview
This program series comprises of two 1-day meetings, first in San Antonio, TX on Friday July 18, 2008, and the second in Denver, CO on Saturday July 19, 2008. This program is designed to provide updates with an integration of important clinical data presented at the major 2008 annual conferences in oncology. This series provides update on new treatment modalities in the management of thoracic, breast, gastrointestinal, prostate/renal cancers, sarcoma/GIST, and hematological malignancies with key data on novel therapeutic agents. This interactive meeting will include didactic sessions, panel and interactive discussions from known thought leaders who will offer their recommendations about the clinical challenges that practicing physicians face in their daily practice.
Target Audience
These symposia are directed toward medical, surgical, and radiation oncologists; hematologists; and fellows practicing in the community or academic institutions. Nurses, physicians’ assistants, pharmacists, PhDs and other individuals interested in the treatment of cancer are also invited to attend.
Learning Objectives
Upon completion of this activity, you should be able to:
- Review recent clinical data regarding the use of agents targeting the EGFR and/or VEGF pathways in the treatment of non-small-cell lung cancer, as well as potential patient selection criteria
- Review novel cytotoxic agents, drugs targeting the HER1, HER2 and VEGF pathways, and their integration into current adjuvant or metastatic treatment regimens for breast cancer
- Explain the impact of EGFR and/or VEGF inhibition in combination with different chemotherapeutic regimens for previously untreated or treated metastatic colorectal cancer
- Outline treatment options for GI cancers, such as hepatic, esophageal, gastric and pancreatic cancers
- Indicate recent treatment options for leukemia, and aggressive and indolent non-Hodgkins lymphoma
- Define the management strategies of newly diagnosed and relapsed multiple myeloma
- Describe the treatment options for the treatment of prostate and renal cell carcinoma
- Review novel targets that can potentially be used for patient selection and for the development of new drugs
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and International Cancer Network. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 6.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing Accreditation Statements
CNA/ANCC
This educational activity for 6.0 contact hours is provided by Postgraduate Institute for Medicine (PIM).
PIM is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
California Board of Registered Nursing
Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 6.0 contact hours.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be mailed to you within three weeks.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
.Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Roberta Granny prior to the live event at 717-531-1078.